| dbo:abstract
|
- Ivor Royston, M.D., is an oncologist, researcher, scientist, entrepreneur and venture capitalist, recognized for his efforts to develop treatments for multiple disease targets and to fund biotechnology companies with promising science, technology or medicines. He speaks regularly at healthcare conferences and symposia throughout the United States, Europe and Asia. One of Royston's most significant achievements may be his successful efforts to partner academic medical research with industry to take potential treatments more quickly from the benchtop to the bedside. After co-founding the first biotechnology company in San Diego, California, he and his associates went on to form or invest in dozens of other biotechs, laying the foundation of the region's thriving biotech cluster, one of the three largest in the United States. As a venture capitalist, Royston invests in start-up companies that have promising technologies for treating and potentially curing diseases, including various forms of cancer. Born in Retford, England, Royston emigrated to the United States with his family in 1954 at age 9, and later, as a 14-year-old, he declared that he would devote his life to curing cancer. Unlike many future scientists, his passion also extended to commerce. This early interest in business manifested itself in a Washington, D.C., high-school investment club of 16 boys — dubbed the Chessmen — that he founded with friends. He also bought and operated an ice cream truck to earn money for college. These divergent interests — medicine and business — would one day catapult Royston beyond his peers, transforming San Diego's economy while improving the health and lives of tens of thousands of patients along the way. (en)
|
| rdfs:comment
|
- Ivor Royston, M.D., is an oncologist, researcher, scientist, entrepreneur and venture capitalist, recognized for his efforts to develop treatments for multiple disease targets and to fund biotechnology companies with promising science, technology or medicines. He speaks regularly at healthcare conferences and symposia throughout the United States, Europe and Asia. One of Royston's most significant achievements may be his successful efforts to partner academic medical research with industry to take potential treatments more quickly from the benchtop to the bedside. (en)
|
